Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR<sup>−</sup>/HER2<sup>+</sup>breast cancersRuth Rodríguez‐Barrueco, José M. Silva, Jiyang Yu et al.|Genes & Development|2015Cited by 121
PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemiaYizhen Li, Jun J. Yang, Takaya Moriyama et al.|Science Advances|2022Cited by 34
Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancyLai Man Natalie Wu, Q. Richard Lu, Feng Zhang et al.|Science Advances|2022Cited by 32
GPR65 Inactivation in Tumor Cells Drives Antigen-Independent CAR T-cell Resistance via Macrophage RemodelingJayadev Mavuluri, Terrence L. Geiger, Yogesh Dhungana et al.|Cancer Discovery|2025Cited by 9
Differentiation-dependent EBF1 activity determines <i>CD22</i> transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S. Escherich, Jun Yang, Elisabeth Paietta et al.|Blood|2025Cited by 5